Shannon M. Gramley

Expérience

West Pharmaceutical Services sells manufacturing and supply rights for SmartDose^® 3.5mL On-Body Delivery System to AbbVieJones Day is advising West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, in the sale of all manufacturing and supply rights for SmartDose^® 3.5mL On-Body Delivery System and associated facilities to AbbVie (NYSE: ABBV) for $112.5 million at close, subject to working capital and other adjustments.

Two Harbors announces acquisition by UWMCJones Day is advising Two Harbors Investment Corp. (NYSE: TWO), a leading MSR focused REIT and one of the largest servicers of conventional mortgages in the country, in its acquisition by UWM Holdings Corporation (NYSE: UWMC), the publicly traded indirect parent of United Wholesale Mortgage, the #1 overall mortgage lender in America, in an all-stock transaction for $1.3 billion in equity value, based on a fixed exchange ratio of 2.3328x.

Riverside acquires ContruentJones Day represented The Riverside Company in the acquisition and financing of Contruent, an Illinois-based provider of lifecycle cost management software for owners of large capital assets and their contractors.

EagleTree Capital sells Northstar Travel Group to JTB Corp.Jones Day advised EagleTree Capital in the sale of Northstar Travel Group, a leading B2B travel industry events, media, and information services company, to JTB Corp., one of Japan’s leading travel solutions providers.